SMTL ID : 2hyy.3 (3 other biounits)

Human Abl kinase domain in complex with imatinib (STI571, Glivec)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

monomer

Ligands

1 x STI: 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE(Non-covalent)

STI.1: 22 residues within 4Å: Chain A: L.21, Y.26, V.29, A.42, V.43, K.44, E.59, V.62, M.63, I.66, V.72, I.86, T.88, F.90, M.91, G.94, I.133, H.134, L.143, A.153, D.154, F.155 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:L.21, A:Y.26, A:A.42, A:I.86, A:T.88, A:L.143, A:D.154 Hydrogen bonds: A:E.59, A:E.59, A:T.88, A:T.88, A:M.91, A:D.154 pi-Stacking: A:Y.26

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cowan-Jacob, S.W. et al., Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia. ACTA CRYSTALLOGR.,SECT.D (2007)

Release Date

2007-01-16

Peptides

Proto-oncogene tyrosine-protein kinase ABL1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

Proto-oncogene tyrosine-protein kinase ABL1

Related Entries With Identical Sequence